DuOtic® (terbinafine and betamethasone acetate otic gel) is the first FDA-approved animal drug intended to treat yeast-only otitis externa in dogs. It is also the first otic drug intended to treat otitis externa that does not contain an antibiotic <Link>.
DuOtic is indicated for the treatment of otitis externa in dogs, associated with susceptible strains of yeast (Malassezia pachydermatis). DuOtic should be administered in the clinic per the label instructions.
Source: Dechra Animal Health, Link. The product will be available for veterinarians to purchase through select veterinary distributors in the near future.
Dechra is excited to add DuOtic® to our expansive dermatology portfolio and offer veterinarians an option to practice antimicrobial stewardship when managing canine otitis.” – Mike Eldred, president